Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calminox is a brand of topical dermatological products developed by Percos, which includes formulations such as Calminox Scalp Lotion, Calminox AD Shampoo, and Calminox Anti-Itch Face & Body Lotion. The antifungal formulations (Calminox Scalp Lotion and Calminox AD Shampoo) contain ketoconazole (2% w/v) as the active ingredient, which is used to treat fungal scalp infections, dandruff, and seborrheic dermatitis by inhibiting fungal ergosterol synthesis. Calminox AD Shampoo is additionally enriched with Ichthyol Pale. The Calminox Anti-Itch formulation is a steroid-free, calamine-free lotion containing hemp seed oil, Physalis angulata extract, Zanthoxylum bungeanum fruit extract, and bisabolol, designed to soothe dry, itchy, and irritated skin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Calminox.